Here are five highlights:
1. K2M’s full-year 2016 revenue will likely reach between $236.1 million to $236.6 million. This range reflects a 9 percent to 10 percent upsurge year-over-year.
2. The company’s Q4 2016 revenue will likely come in between $61.3 million and $61.8 million, reflecting a 13 percent to 14 percent increase year-over-year.
3. K2M anticipates domestic Q4 2016 revenue to fall between $47.4 million and $47.7 million. This range reflects an increase of 21 percent year-over-year.
4. The company reports U.S. complex spine growth in excess of 17 percent year-over-year for Q4 2016; U.S. minimally invasive surgery growth in excess of 35 percent year-over-year; and U.S. degenerative growth in excess of 18 percent year-over-year.
5. The company’s international Q4 2016 revenue will likely be between $13.9 million and $14.1 million, reflecting a 6 percent to 7 percent decrease year-over-year.
More articles on devices:
Global SCS devices market to grow at 4.8% CAGR to 2020: 3 key points
Orthofix earns FDA, CE Mark approvals for bone growth stimulators: 6 key points
Expanding Orthopedics reports 100%+ sales growth for FLXfit cage — 5 highlights
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
